Headline Details

Hitting cancer early: AstraZeneca's bid to outmaneuver rivals

Published on: Fri, 06 Jul 2018 7:28:16 UTC
News Agency: Reuters
Description:
AstraZeneca suffered its biggest daily share price drop a year ago after a key cancer drug trial failed amid feverish speculation the chief executive might quit.

Click here for FULL Story on Reuters

Also happening now

HeadlineNews Agency
Russia, China abstain in U.N. vote on Syria cross-border aid Reuters
EU offers Britain some assurances over Brexit backstop Reuters
EU leaders agreed Irish backstop should only be temporary: Austria's Kurz Reuters
Nicaragua lawmakers block operation of NGOs critical of President Ortega Reuters
Main suspect in Strasbourg attack killed in gun battle with police -officials Reuters